The T1D Fund Strengthens Expertise With Appointment of Biotech Industry Veteran and Cell Therapy Expert Teresa Foy, Ph.D., to Advance Next Generation of Type 1 Diabetes (“T1D”) Therapies
Former Bristol Myers Squibb and Celgene executive to strengthen the Fund’s impact strategy and fuel transformative investments across innovative modalities BOSTON, Jan. 21, 2026 /PRNewswire/ — The T1D Fund: A Breakthrough…